of 7 days of treatment with two doses of dotinurad monotherapy, and to evaluate the effect of dotinurad, as monotherapy and in combination with allopurinol, versus allopurinol monotherapy ...

Choi notes that many of these lifestyle changes will not only reduce uric acid levels and the risk of recurrent gout but will also improve the health status of those with comorbidities ...

MACHINE LEARNING MODEL USING DATA THAT CAN BE COLLECTED IN DAILY MEDICAL EXAMINATIONS BY PRIMARY CARE PHYSICIANS TOKYO, Feb 14, 2025 - (JCN Newswire) - Oita University and Eisai Co., Ltd. (Eisai) ...

Japanese drugmaker Eisai (TYO: 4523) today announced that it has received approval for Urece (dotinurad) from the National Medical Products Administration (NMPA) in China as a treatment for gout ...

OBJECTIVES To study the efficacy of allopurinol and benzbromarone to reduce serum urate concentrations in patients with primary chronic gout. METHODS Prospective, parallel, open study of 86 ...

After hours: February 14 at 6:36:30 PM EST Loading Chart for FBIO ...

Objective: The study focuses on comparing the efficacy of a low-dose combination of febuxostat and benzbromarone versus each drug used alone for the treatment of gout. Methods: A prospective, ...

With the changes in modern life, hyperuricemia (HUA) has become a serious universal health issue, leading to rising morbidity and mortality. Characterized by elevated levels of UA, HUA has become an ...

After hours: 14 February at 6:36:30 pm GMT-5 ...

After hours: 31 January at 7:54:22 pm GMT-5 ...